Literature DB >> 32750253

Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis.

Anthony J Fischer1, Sachinkumar B Singh1, Mason M LaMarche1, Lucas J Maakestad1, Zoe E Kienenberger1, Tahuanty A Peña1,2, David A Stoltz2, Dominique H Limoli3.   

Abstract

Rationale: Staphylococcus aureus and Pseudomonas aeruginosa often infect the airways in cystic fibrosis (CF). Because registry studies show higher prevalence of P. aeruginosa versus S. aureus in older patients with CF, a common assumption is that P. aeruginosa replaces S. aureus over time. In vitro, P. aeruginosa can outgrow and kill S. aureus. However, it is unknown how rapidly P. aeruginosa replaces S. aureus in patients with CF.
Methods: We studied a longitudinal cohort of children and adults with CF who had quantitative sputum cultures. We determined the abundance of P. aeruginosa and S. aureus in cfu/ml. We determined the duration and persistence of infections and measured longitudinal changes in culture positivity and abundance for each organism.Measurements and Main
Results: Between 2004 and 2017, 134 patients had ≥10 quantitative cultures, with median observation time of 10.15 years. One hundred twenty-four patients had at least one positive culture for P. aeruginosa, and 123 had at least one positive culture for S. aureus. Both species had median abundance of >106 cfu/ml. Culture abundance was stable over time for both organisms. There was an increase in the prevalence of S. aureus/P. aeruginosa coinfection but no decrease in S. aureus prevalence within individuals over time.Conclusions: S. aureus and P. aeruginosa are abundant in CF sputum cultures. Contrary to common assumption, we found no pattern of replacement of S. aureus by P. aeruginosa. Many patients with CF have durable long-term coinfection with these organisms. New strategies are needed to prevent and treat these infections.

Entities:  

Keywords:  Pseudomonas aeruginosa sputum; Staphylococcus aureus; cystic fibrosis; methicillin-resistant Staphylococcus aureus

Mesh:

Substances:

Year:  2021        PMID: 32750253      PMCID: PMC7874317          DOI: 10.1164/rccm.202004-1322OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  38 in total

1.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.

Authors:  J Kirk Harris; Brandie D Wagner; Edith T Zemanick; Charles E Robertson; Mark J Stevens; Sonya L Heltshe; Steven M Rowe; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2020-02

Review 3.  Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.

Authors:  Angela T Nguyen; Amanda G Oglesby-Sherrouse
Journal:  Appl Microbiol Biotechnol       Date:  2016-05-28       Impact factor: 4.813

4.  Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.

Authors:  Daniel J Wolter; Julia C Emerson; Sharon McNamara; Anne M Buccat; Xuan Qin; Elizabeth Cochrane; Laura S Houston; Geraint B Rogers; Peter Marsh; Karandeep Prehar; Christopher E Pope; Marcella Blackledge; Eric Déziel; Kenneth D Bruce; Bonnie W Ramsey; Ronald L Gibson; Jane L Burns; Lucas R Hoffman
Journal:  Clin Infect Dis       Date:  2013-04-26       Impact factor: 9.079

5.  Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.

Authors:  Katherine B Hisert; Sonya L Heltshe; Christopher Pope; Peter Jorth; Xia Wu; Rachael M Edwards; Matthew Radey; Frank J Accurso; Daniel J Wolter; Gordon Cooke; Ryan J Adam; Suzanne Carter; Brenda Grogan; Janice L Launspach; Seamas C Donnelly; Charles G Gallagher; James E Bruce; David A Stoltz; Michael J Welsh; Lucas R Hoffman; Edward F McKone; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

6.  Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis.

Authors:  Elliott C Dasenbrook; William Checkley; Christian A Merlo; Michael W Konstan; Noah Lechtzin; Michael P Boyle
Journal:  JAMA       Date:  2010-06-16       Impact factor: 56.272

7.  Iron-Mediated Control of Pseudomonas aeruginosa-Staphylococcus aureus Interactions in the Cystic Fibrosis Lung.

Authors:  Patricia M Barnabie; Marvin Whiteley
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

8.  Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.

Authors:  Elliott C Dasenbrook; Christian A Merlo; Marie Diener-West; Noah Lechtzin; Michael P Boyle
Journal:  Am J Respir Crit Care Med       Date:  2008-07-31       Impact factor: 21.405

9.  Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.

Authors:  D H Limoli; J Yang; M K Khansaheb; B Helfman; L Peng; A A Stecenko; J B Goldberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

10.  Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

Authors:  B W Ramsey; K R Wentz; A L Smith; M Richardson; J Williams-Warren; D L Hedges; R Gibson; G J Redding; K Lent; K Harris
Journal:  Am Rev Respir Dis       Date:  1991-08
View more
  13 in total

1.  CF-Seq, an accessible web application for rapid re-analysis of cystic fibrosis pathogen RNA sequencing studies.

Authors:  Samuel L Neff; Thomas H Hampton; Charles Puerner; Liviu Cengher; Georgia Doing; Alexandra J Lee; Katja Koeppen; Ambrose L Cheung; Deborah A Hogan; Robert A Cramer; Bruce A Stanton
Journal:  Sci Data       Date:  2022-06-16       Impact factor: 8.501

2.  The Depletion Mechanism Actuates Bacterial Aggregation by Exopolysaccharides and Determines Species Distribution & Composition in Bacterial Aggregates.

Authors:  Patrick R Secor; Lia A Michaels; DeAnna C Bublitz; Laura K Jennings; Pradeep K Singh
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

3.  Systematic identification of molecular mediators of interspecies sensing in a community of two frequently coinfecting bacterial pathogens.

Authors:  Tiffany M Zarrella; Anupama Khare
Journal:  PLoS Biol       Date:  2022-06-21       Impact factor: 9.593

4.  Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura Camus; Paul Briaud; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  A population-level strain genotyping method to study pathogen strain dynamics in human infections.

Authors:  Sarah J Morgan; Samantha L Durfey; Sumedha Ravishankar; Peter Jorth; Wendy Ni; Duncan T Skerrett; Moira L Aitken; Edward F McKone; Stephen J Salipante; Matthew C Radey; Pradeep K Singh
Journal:  JCI Insight       Date:  2021-12-22

6.  MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis.

Authors:  Harry S Porterfield; Lucas J Maakestad; Mason M LaMarche; Andrew L Thurman; Zoe E Kienenberger; Nicholas J Pitcher; Alexis R Hansen; Christian F Zirbes; Linda Boyken; Bethany L Muyskens; Alejandro A Pezzulo; Sachinkumar B Singh; Erik Twait; Bradley Ford; Daniel J Diekema; Valérie Reeb; Anthony J Fischer
Journal:  Pediatr Pulmonol       Date:  2021-07-16

Review 7.  Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism.

Authors:  Christopher M Horn; Tammy Kielian
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

8.  Not Quite the Bully in the Schoolyard: Staphylococcus aureus Can Survive and Coexist with Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

Authors:  Daniel J Wolter; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

9.  One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway.

Authors:  Fabrice Jean-Pierre; Arsh Vyas; Thomas H Hampton; Michael A Henson; George A O'Toole
Journal:  mBio       Date:  2021-03-16       Impact factor: 7.867

10.  Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.

Authors:  Marie K Wieneke; Felix Dach; Claudia Neumann; Dennis Görlich; Lena Kaese; Theo Thißen; Angelika Dübbers; Christina Kessler; Jörg Große-Onnebrink; Peter Küster; Holger Schültingkemper; Bianca Schwartbeck; Johannes Roth; Jerzy-Roch Nofer; Janina Treffon; Julia Posdorfer; Josefine Marie Boecken; Mariele Strake; Miriam Abdo; Sophia Westhues; Barbara C Kahl
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.